U.S. flag

An official website of the United States government

NM_000157.4(GBA1):c.882T>G (p.His294Gln) AND not specified

Germline classification:
Uncertain significance (3 submissions)
Last evaluated:
Mar 21, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002247685.14

Allele description [Variation Report for NM_000157.4(GBA1):c.882T>G (p.His294Gln)]

NM_000157.4(GBA1):c.882T>G (p.His294Gln)

Genes:
LOC106627981:GBA recombination region [Gene]
GBA1:glucosylceramidase beta 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q22
Genomic location:
Preferred name:
NM_000157.4(GBA1):c.882T>G (p.His294Gln)
Other names:
H255Q
HGVS:
  • NC_000001.11:g.155237458A>C
  • NG_009783.1:g.12240T>G
  • NG_042867.1:g.3920A>C
  • NM_000157.4:c.882T>GMANE SELECT
  • NM_001005741.2(GBA):c.882T>G
  • NM_001005741.3:c.882T>G
  • NM_001005742.3:c.882T>G
  • NM_001171811.2:c.621T>G
  • NM_001171812.2:c.735T>G
  • NP_000148.2:p.His294Gln
  • NP_001005741.1:p.His294Gln
  • NP_001005741.1:p.His294Gln
  • NP_001005742.1:p.His294Gln
  • NP_001165282.1:p.His207Gln
  • NP_001165283.1:p.His245Gln
  • NC_000001.10:g.155207249A>C
  • NM_000157.3:c.882T>G
  • NM_000157.4:c.882T>G
  • NM_001005741.2(GBA):c.882T>G
  • NM_001005741.2:c.882T>G
  • NM_001005741.3:c.882T>G
  • NM_001005742.2:c.882T>G
  • NM_001005742.3:c.882T>G
  • P04062:p.His294Gln
Protein change:
H207Q; HIS255GLN
Links:
UniProtKB: P04062#VAR_009040; OMIM: 606463.0047; dbSNP: rs367968666
NCBI 1000 Genomes Browser:
rs367968666
Molecular consequence:
  • NM_000157.4:c.882T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001005741.3:c.882T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001005742.3:c.882T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001171811.2:c.621T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001171812.2:c.735T>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000697597Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Mar 21, 2024)
germlineclinical testing

PubMed (10)
[See all records that cite these PMIDs]

Citation Link,

SCV002517121Mendelics
criteria provided, single submitter

(Mendelics Assertion Criteria 2019)
Uncertain significance
(May 4, 2022)
germlineclinical testing

Citation Link,

SCV002756331Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Apr 18, 2022)
germlineclinical testing

PubMed (9)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Glucocerebrosidase mutations in a Serbian Parkinson's disease population.

Kumar KR, Ramirez A, Göbel A, Kresojević N, Svetel M, Lohmann K, M Sue C, Rolfs A, Mazzulli JR, Alcalay RN, Krainc D, Klein C, Kostic V, Grünewald A.

Eur J Neurol. 2013 Feb;20(2):402-5. doi: 10.1111/j.1468-1331.2012.03817.x. Epub 2012 Jul 20.

PubMed [citation]
PMID:
22812582

β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease.

Moraitou M, Hadjigeorgiou G, Monopolis I, Dardiotis E, Bozi M, Vassilatis D, Vilageliu L, Grinberg D, Xiromerisiou G, Stefanis L, Michelakakis H.

Mol Genet Metab. 2011 Sep-Oct;104(1-2):149-52. doi: 10.1016/j.ymgme.2011.06.015. Epub 2011 Jun 24.

PubMed [citation]
PMID:
21745757
See all PubMed Citations (15)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000697597.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (10)

Description

Variant summary: GBA1 c.882T>G (p.His294Gln) results in a non-conservative amino acid change located in the Glycosyl hydrolase family 30, TIM-barrel domain (IPR033453) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00018 in 1613960 control chromosomes in the gnomAD database, including 1 homozygotes. This frequency is not significantly higher than estimated for a pathogenic variant in GBA1 causing Gaucher Disease (0.00018 vs 0.005), allowing no conclusion about variant significance. c.882T>G (also known as H255Q) is commonly reported in patients with Gaucher disease as a part of complex allele (examples: Miocic_2005, Santamaria_2008, Kumar_2013, Kumar_2013, Gragnaniello_2023). A few instances of H294Q variant in isolation has been reported in Parkinsons disease patients (Kalinderi_2009, Benitez_2016, Palomba_ 2023). In the expression studies, constructs bearing the H294Q in isolation retained a significant residual enzymatic activity (~ 56.4% and ~76% of the wild type value) (Santamaria_2008, Snchez-Oll_2009). The same studies reported that D448H mutant severely reduces the enzymatic activity. Thus D448H could be the driver mutation in the complex allele. Further, one of those studies showed that the double mutant p.[D448H;H294Q] causes more pronounced functional impairment than p.D448H mutant alone (Santamaria_2008), suggesting that the H294Q could be a modifier of D488H variant which is consistent with clinical findings. The following publications have been ascertained in the context of this evaluation (PMID: 10649495, 15605411, 18429048, 21745757, 22812582, 19383421, 27094865, 37009750, 36609826, 19167250). ClinVar contains an entry for this variant (Variation ID: 242810). Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Mendelics, SCV002517121.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Ambry Genetics, SCV002756331.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (9)

Description

The c.882T>G (p.H294Q) alteration is located in exon 8 (coding exon 7) of the GBA gene. This alteration results from a T to G substitution at nucleotide position 882, causing the histidine (H) at amino acid position 294 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024